Inflammatory diseases do not increase the risk of clotting after COVID

  This is evident from a recent study published in the journal JAMA network openedResearchers in Canada investigated whether coronavirus disease 2019 (COVID-19) patients with immune-mediated inflammatory diseases (IMIDs) were at higher risk of experiencing venous thromboembolism after recovery from severe acute respiratory syndrome coronavirus 2 (SARS-CoV- 2) infections compared to COVID-19 patients without IMIDs….